Long-Term Safety Study of MT-2412 in Japanese Patients With Type 2 Diabetes
NCT02220907
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
153
Enrollment
INDUSTRY
Sponsor class
Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG:
Teneligliptin/Canagliflozin
Sponsor
Tanabe Pharma Corporation